Recent Updates
Recently added Catalysts
HLF Positive Sentiment

Herbalife Reaffirms Third Quarter and Full Year 2026 Guidance

Monday, August 31, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Herbalife Ltd. has reaffirmed its financial guidance for the third quarter and full year of 2026, initially provided in August 2026. The company anticipates year-over-year net sales growth for both periods, indicating a stable financial outlook. Additionally, Herbalife has confirmed its adjusted EBITDA guidance for the same timeframe.

Market Sentiment Analysis

POSITIVE FACTORS

  • Herbalife expects year-over-year net sales growth.
  • The company reaffirms its financial guidance for 2026.
  • Positive outlook for both third quarter and full year.

Full Press Release Details

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today reaffirmed the third quarter and full-year 2026 financial guidance it provided on August 5, 2026 in connection with its second quarter 2026 earnings release. The Company continues to expect year-over-year net sales growth for both the third quarter and the full year 2026, on a reported and constant currency basis2, and reaffirms its adjusted EBITDA1 guidance for both pe

Frequently Asked Questions

What financial guidance did Herbalife reaffirm?

Herbalife reaffirmed its third quarter and full-year 2026 financial guidance.

What growth does Herbalife expect for 2026?

The company expects year-over-year net sales growth for both periods.

When was the original guidance provided?

The original guidance was provided on August 5, 2026.

What does EBITDA stand for?

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization.

ShareAdd on Google
Tags: HLF Viatris Investor Conferences Healthcare Herbalife 2026 guidance net sales growth adjusted EBITDA
Last updated: Aug 31, 2026

Biotech snapshot

Cash runway
$371M liquidity · $0M/mo burn
Low dilution risk